During the past decade, Ospedale Civile di guastalla conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Civile di guastalla" #1 sponsor was "Heart Care Foundation" with 4 trials, followed by "Consorzio Oncotech" with 2 trials sponsored, "National Cancer Institute, Naples" with 2 trials sponsored, "Azienda Ospedaliero-Universitaria di Parma" with 1 trials sponsored and "Azienda Unità Sanitaria Locale Reggio Emilia" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Civile di guastalla" #1 collaborator was "Clinical Research Technology S.r.l." with 2 trials as a collaborator, "Biotronik SE & Co. KG" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Istituto Di Ricerche Farmacologiche Mario Negri" with 1 trials as a collaborator and "Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Civile di guastalla" are "Atrial Fibrillation" (2 trials), "Cancer" (2 trials), "Human Epidermal Growth Factor 2 Negative Carcinoma of Breast" (2 trials), "Metastatic Breast Cancer" (2 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "Ospedale Civile di guastalla" in a lesser frequency.

Most popular intervention types in "Ospedale Civile di guastalla" are "Drug" (8 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (3 trials), "5-FU" (1 trials), "Atrial Fibrillation" (1 trials), "Calcium levofolinate" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Civile di guastalla" are 10 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Civile di guastalla". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Ospedale Civile di guastalla, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Civile di guastalla, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".